+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of oral imidazoles in therapy of systemic candidosis in a murine model



Comparison of oral imidazoles in therapy of systemic candidosis in a murine model



Abstracts Of The Annual Meeting Of The American Society For Microbiology: Stract F1




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 027975956

Download citation: RISBibTeXText


Related references

Susceptibility of Candida albicans to photodynamic therapy in a murine model of oral candidosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 109(3): 0-401, 2010

Chemotherapy of chronic mucocutaneous candidosis and systemic candidosis treated by oral ketoconazole. Chemotherapie von Oberflachen , Organ und Systemmykosen I Deutsches Nizoral Symposium: 58-68, 1982

Breakdown of mucosal immunity in the gut and resultant systemic sensitization by oral antigens in a murine model for systemic lupus erythematosus. Journal of Immunology 174(9): 5499-5506, 2005

Evaluation of himachalol in murine systemic candidosis. Journal de Mycologie Medicale 9(4): 217-220, 1999

Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis. Journal of Antimicrobial ChemoTherapy 47(2): 183-186, 2001

Efficacy of the partricin derivative, IB-643, against systemic murine candidosis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 469, 1998

Differential effects of CD4+ and CD8+ cells in acute, systemic murine candidosis. Journal of Leukocyte Biology 51(3): 305-306, 1992

Modulation of experimental systemic murine candidosis by intravenous pepstatin. Zentralblatt fuer Bakteriologie 273(3): 391-403, 1990

Experimental oral murine candidosis and attempts of prevention. Journal de Mycologie Medicale 9(1): 10-15, 1999

Development and validation of a new localized candidosis model The murine mycotic mastitis model. Mycoses 42(3): 134-135, 1999

Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis. Dental Update 27(4): 165-70 172-4, 2000

Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Molecular Microbiology 29(2): 605-615, 1998

Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus. Arthritis and Rheumatism 58(7): 2098-2104, 2008

Clinical use of oral nystatin in the prevention of systemic candidosis in patients at particular risk. Mycoses 39(9-10): 329-339, 1996